!ID 0000001
!v001!235861
!v002!77
!ID 0000002
!v001!235877
!v002!93
!ID 0000003
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!5
!v701!1
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p align="right"><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="2"><b>ARTIGOS    ORIGINAIS</b></font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000004
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!6
!v701!2
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p>&nbsp;</p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000005
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!7
!v701!3
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="4"><b><a name="top10"></a>Dermatoses    em pacientes infectados pelo HIV com a contagem de linf&oacute;citos CD4</b>    </font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000006
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!8
!v701!4
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p>&nbsp;</p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000007
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!9
!v701!5
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="3"><b>Dermatological    disease among HIV-infected patients with CD4-lymphocyte count</b></font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000008
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!10
!v701!6
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p>&nbsp;</p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000009
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!11
!v701!7
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p>&nbsp;</p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000010
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!12
!v701!8
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Lessandra Michelim<sup>I</sup>;    Jos&eacute; Luiz Atti<sup>II</sup>; Daniel Panarotto<sup>II</sup>; Louise Lovatto<sup>II,    </sup><a href="#back1"><sup>*</sup></a>; M&aacute;rcio Manozzo Boniatti<sup>II,    </sup><a href="#back1"><sup>*</sup></a></b></font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000011
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!13
!v701!9
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><sup>I</sup>Servi&ccedil;o    de Controle de Infec&ccedil;&atilde;o Hospitalar. Hospital Geral de Caxias do    Sul. Caxias do Sul, RS, Brasil    ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000012
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!14
!v701!10
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<br>   <sup>II</sup>Departamento de Cl&iacute;nica M&eacute;dica. Universidade de Caxias    do Sul. Caxias do Sul, RS, Brasil</font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000013
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!15
!v701!11
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><a href="#back10">Endere&ccedil;o    para correspond&ecirc;ncia</a></font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000014
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!16
!v701!12
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p>&nbsp;</p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000015
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!17
!v701!13
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p>&nbsp;</p> <hr size="1" noshade>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000016
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!18
!v701!14
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>RESUMO</b></font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000017
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!19
!v701!15
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>OBJETIVO: </b>Correlacionar    a preval&ecirc;ncia das doen&ccedil;as dermatol&oacute;gicas entre pacientes    infectados pelo HIV com a contagem de linf&oacute;citos CD4.    ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000018
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!20
!v701!16
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<br>   </font><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>M&Eacute;TODOS:    </b></font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Estudo    de s&eacute;rie de casos realizado na regi&atilde;o de Caxias do Sul, Estado    do Rio Grande do Sul. Os dados foram coletados por meio da revis&atilde;o de    prontu&aacute;rios de pacientes com infec&ccedil;&atilde;o pelo HIV internados    em hospital p&uacute;blico (198 pacientes, per&iacute;odo de mar&ccedil;o de    1998 a junho de 2002) ou atendidos no ambulat&oacute;rio central universit&aacute;rio    (40 pacientes, per&iacute;odo de mar&ccedil;o a junho de 2002). As vari&aacute;veis    analisadas foram: idade, sexo, contagem de linf&oacute;citos CD4, carga viral    e doen&ccedil;as dermatol&oacute;gicas apresentadas pelo paciente. Os testes    estat&iacute;sticos utilizados foram o Teste <i>t</i> de <i>Student</i>, o de    Spearman e o do qui-quadrado.    ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000019
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!21
!v701!17
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<br>   <b>RESULTADOS:    </b>A freq&uuml;&ecirc;ncia de doen&ccedil;a dermatol&oacute;gica foi de 67,2%    entre os pacientes hospitalizados e de 75,0% entre os pacientes ambulatoriais.    Candid&iacute;ase oral foi a doen&ccedil;a dermatol&oacute;gica mais prevalente.    Na popula&ccedil;&atilde;o hospitalar, a m&eacute;dia de c&eacute;lulas CD4    foi menor entre os pacientes com doen&ccedil;a dermatol&oacute;gica dos sem    doen&ccedil;a dermatol&oacute;gica (142,34 c&eacute;lulas/mm<sup>3</sup> <i>vs</i>    512,35 c&eacute;lulas/mm<sup>3</sup>, respectivamente; p=0,018). O mesmo fen&ocirc;meno    foi observado na popula&ccedil;&atilde;o ambulatorial (138,88 c&eacute;lulas/mm<sup>3</sup>    e 336,21 c&eacute;lulas/mm<sup>3</sup>, respectivamente; p=0,001). Verificou-se,    em ambas as popula&ccedil;&otilde;es, uma correla&ccedil;&atilde;o negativa    entre a contagem de CD4 e o n&uacute;mero total de doen&ccedil;as dermatol&oacute;gicas    apresentadas pelo paciente (p=0,000, popula&ccedil;&atilde;o hospitalar; p=0,000,    popula&ccedil;&atilde;o ambulatorial).    ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000020
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!22
!v701!18
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<br>   <b>CONCLUS&Otilde;ES: </b>As doen&ccedil;as dermatol&oacute;gicas s&atilde;o    altamente prevalentes entre os pacientes infectados pelo HIV, sendo que a freq&uuml;&ecirc;ncia    e o n&uacute;mero dessas manifesta&ccedil;&otilde;es correlacionam-se bem com    o <i>status</i> imunol&oacute;gico do paciente e com a progress&atilde;o da    doen&ccedil;a.</font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000021
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!23
!v701!19
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Descritores:    </b>Infec&ccedil;&otilde;es por HIV. S&iacute;ndrome de imunodefici&ecirc;ncia    adquirida. Infec&ccedil;&otilde;es oportunistas relacionadas com a Aids. Dermatopatias.    Contagem de linf&oacute;cito CD4. Imunossupress&atilde;o.</font></p> <hr size="1" noshade>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000022
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!24
!v701!20
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>ABSTRACT</b></font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000023
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!25
!v701!21
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>OBJECTIVE: </b>To    correlate the prevalence of dermatological diseases among HIV-infected patient    with CD4-lymphocyte count.    ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000024
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!26
!v701!22
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<br>   <b>METHODS: </b>A case series study was carried out in the region of Caxias    do Sul, state of Rio Grande do Sul State, Brazil. Data was collected by reviewing    the records of HIV-infected patients admitted to a public hospital (198 patients    from March 1998 to June 2002) or seen at the university outpatient clinic (40    patients from March to June 2002). The variables analyzed were: age, sex, CD4-lymphocyte    count, viral load, and dermatological diseases. Statistical analyses were performed    using Student's t-test, Spearman's and Chi-Square tests.    ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000025
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!27
!v701!23
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<br>   <b>RESULTS: </b>The frequency of dermatological disease was 67.2% among hospitalized    patients and 75.0% among outpatients. Oral candidiasis was the most prevalent    dermatological disease. Among the hospital population, the average CD4 count    was lower among patients with dermatological disease than among those with no    disease (142.34 cells/mm<sup>3</sup> vs 512.35 cells/mm<sup>3</sup>, respectively;    p=0.018). The same phenomenon was observed in outpatient population (138.88    cells/mm<sup>3</sup> and 336.21 cells/mm<sup>3</sup>, respectively; p=0.001).    In both populations, a negative correlation was found between CD4 count and    the total number of dermatological diseases by a patient (p=0.000, hospital    population, p=0.000, outpatient population).    ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000026
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!28
!v701!24
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<br>   <b>CONCLUSIONS: </b>Dermatological diseases are highly prevalent among HIV-infected    patients and the frequency and number of these manifestations are well correlated    to the patient's immune status and disease progression.</font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000027
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!29
!v701!25
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Keywords: </b>HIV    infections. Acquired immunodeficiency syndrome. AIDS-related opportunistic infections.    Skin diseases. CD4-lymphocyte count. Immunosuppression.</font></p> <hr size="1" noshade>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000028
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!30
!v701!26
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p>&nbsp;</p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000029
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!31
!v701!27
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p>&nbsp;</p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000030
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!32
!v701!28
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="3"><b>INTRODU&Ccedil;&Atilde;O</b></font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000031
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!33
!v701!29
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">A infec&ccedil;&atilde;o    pelo v&iacute;rus HIV &eacute; uma pandemia, com casos notificados em quase    todos os pa&iacute;ses. Estima-se que mais de 30 milh&otilde;es de pessoas vivam    com o v&iacute;rus HIV em todo o mundo, com 16.000 novos casos sendo diagnosticados    a cada dia.<sup>2</sup> Foram diagnosticados 41.311 novos casos de Aids, somente    no ano de 2001, nos Estados Unidos.<sup>3</sup> No Brasil, estima-se que 597    mil sejam portadores do v&iacute;rus da Aids.<sup>16</sup></font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000032
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!34
!v701!30
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">As doen&ccedil;as    dermatol&oacute;gicas est&atilde;o entre as manifesta&ccedil;&otilde;es mais    freq&uuml;entes da doen&ccedil;a. Com efeito, a pele &eacute; afetada em quase,    todos esses pacientes.<sup>10</sup> Os agressores podem ser bact&eacute;rias,    v&iacute;rus, fungos ou outros agentes n&atilde;o infecciosos.<sup>15</sup>    Al&eacute;m disso, as doen&ccedil;as dermatol&oacute;gicas podem ser o sinal    mais precoce ou ser o &uacute;nico problema sofrido pelo paciente durante parte    do curso da infec&ccedil;&atilde;o pelo HIV.<sup>10</sup> Por isso, ami&uacute;de,    o diagn&oacute;stico da doen&ccedil;a &eacute; suspeitado pela les&atilde;o    dermatol&oacute;gica apresentada pelo paciente.<sup>11,12</sup></font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000033
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!35
!v701!31
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Al&eacute;m de    serem freq&uuml;entes, as doen&ccedil;as dermatol&oacute;gicas podem apresentar-se    de forma at&iacute;pica em pacientes imunodeficientes, o que pode dificultar    o seu diagn&oacute;stico adequado.<sup>10</sup> Ademais, a resposta ao tratamento    pode ser menos eficaz que a esperada.<sup>10</sup></font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000034
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!36
!v701!32
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&Eacute; justamente    a apresenta&ccedil;&atilde;o at&iacute;pica de doen&ccedil;as dermatol&oacute;gicas    comuns ou o aparecimento de doen&ccedil;as dermatol&oacute;gicas pouco prevalentes    que alerta o examinador para a presen&ccedil;a de imunodepress&atilde;o, levando    ao diagn&oacute;stico da doen&ccedil;a Aids<sup>5</sup> (n&atilde;o apenas da    infec&ccedil;&atilde;o pelo v&iacute;rus HIV), e servindo como marcadores de    progress&atilde;o da doen&ccedil;a.<sup>5,6,9,13</sup> Graves infec&ccedil;&otilde;es    oportunistas podem apresentar-se primeiramente na pele, sendo tais les&otilde;es    dermatol&oacute;gicas poss&iacute;vel marcador de doen&ccedil;as potencialmente    fatais.<sup>10</sup></font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000035
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!37
!v701!33
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Dada a relativa    facilidade do exame da pele e pelo fato do diagn&oacute;stico da maioria das    doen&ccedil;as dermatol&oacute;gicas ser acess&iacute;vel pela inspe&ccedil;&atilde;o    e bi&oacute;psia, a avalia&ccedil;&atilde;o da pele persiste como elemento importante    no processo diagn&oacute;stico e no acompanhamento dos pacientes infectados    pelo HIV.<sup>5</sup></font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000036
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!38
!v701!34
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Apesar de v&aacute;rios    estudos internacionais<sup>6,7,9,17</sup> revelarem a exist&ecirc;ncia de correla&ccedil;&atilde;o    negativa entre contagem de linf&oacute;citos CD4 e doen&ccedil;as dermatol&oacute;gicas,    n&atilde;o foram encontrados estudos nacionais que tivessem como objetivo analisar    essa associa&ccedil;&atilde;o. Justifica-se ainda o presente estudo pela varia&ccedil;&atilde;o    de doen&ccedil;as dermatol&oacute;gicas verificada entre diferentes pa&iacute;ses    ou regi&otilde;es, sendo relevante conhecer o espectro de doen&ccedil;as dermatol&oacute;gicas    entre pacientes infectados pelo HIV, de cada regi&atilde;o.</font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000037
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!39
!v701!35
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Assim, o objetivo    do presente estudo &eacute; verificar a preval&ecirc;ncia das doen&ccedil;as    dermatol&oacute;gicas entre pacientes infectados pelo HIV, destacando as les&otilde;es    mais comumente encontradas e correlacionando-as com a contagem de linf&oacute;citos    CD4.</font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000038
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!40
!v701!36
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p>&nbsp;</p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000039
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!41
!v701!37
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="3"><b>M&Eacute;TODOS</b></font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000040
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!42
!v701!38
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Trata-se de estudo    de s&eacute;rie de casos. Os dados foram coletados por meio de revis&atilde;o    de prontu&aacute;rios de todos os pacientes com diagn&oacute;stico de infec&ccedil;&atilde;o    pelo v&iacute;rus HIV, internados em hospital p&uacute;blico de Caxias do Sul,    RS (per&iacute;odo de mar&ccedil;o de 1998 a junho de 2002) e/ou atendidos no    ambulat&oacute;rio central universit&aacute;rio (per&iacute;odo de mar&ccedil;o    a junho de 2002). Ambos s&atilde;o unidades universit&aacute;rias de atendimento    aos pacientes da rede p&uacute;blica de sa&uacute;de.</font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000041
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!43
!v701!39
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Os pacientes foram    divididos em dois grupos: o grupo hospitalar, com uma popula&ccedil;&atilde;o    final de 198 pacientes, e o grupo ambulatorial, com uma popula&ccedil;&atilde;o    final de 40 pacientes. Um mesmo paciente podia fazer parte dos dois grupos,    desde que tivesse sido internado no hospital e realizado consulta no ambulat&oacute;rio.</font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000042
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!44
!v701!40
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Foram analisadas    as seguintes informa&ccedil;&otilde;es contidas nos prontu&aacute;rios: idade,    sexo, contagem de linf&oacute;citos CD4 (n&uacute;mero de linf&oacute;citos    CD4 por mm<sup>3</sup> de sangue), carga viral e doen&ccedil;as dermatol&oacute;gicas    apresentadas pelo paciente. Foram descritas apenas as doen&ccedil;as dermatol&oacute;gicas    que possu&iacute;am diagn&oacute;stico de certeza, seja porque seu diagn&oacute;stico    cl&iacute;nico era evidente ou, quando duvidoso, por confirma&ccedil;&atilde;o    pelo exame complementar, conforme prontu&aacute;rio dos pacientes. Para estabelecer    a correla&ccedil;&atilde;o entre contagem de linf&oacute;citos CD4 e doen&ccedil;a    dermatol&oacute;gica, estabeleceu-se, arbitrariamente, como tempo v&aacute;lido    para determinada contagem de CD4 o per&iacute;odo de quatro meses (dois meses    antes e dois meses ap&oacute;s a coleta para determina&ccedil;&atilde;o do CD4).    Fora desse per&iacute;odo, n&atilde;o se estabeleceu uma correla&ccedil;&atilde;o    entre a doen&ccedil;a dermatol&oacute;gica descrita e a contagem de linf&oacute;citos    CD4.</font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000043
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!45
!v701!41
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">O presente estudo    foi aprovado pelo comit&ecirc; de &eacute;tica do Hospital Geral de Caxias do    Sul, respons&aacute;vel pela avalia&ccedil;&atilde;o das pesquisas realizadas    nessa institui&ccedil;&atilde;o.</font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000044
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!46
!v701!42
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Os testes estat&iacute;sticos    utilizados foram o Teste <i>t</i> de <i>Student</i>, o teste de Spearman e o    teste do qui-quadrado, pelo programa SPSS, vers&atilde;o 11.0. O intervalo de    confian&ccedil;a nas an&aacute;lises estat&iacute;sticas foi de 95%.</font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000045
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!47
!v701!43
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p>&nbsp;</p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000046
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!48
!v701!44
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="3"><b>RESULTADOS</b></font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000047
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!49
!v701!45
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Entre os 198 pacientes    do hospital cujos prontu&aacute;rios foram revisados, 125 (63,1%; IC 95%: 56,0-69,9)    eram do sexo masculino e 73 (36,9%; IC 95%: 30,1-44,0) do sexo feminino. A m&eacute;dia    de idade para essa popula&ccedil;&atilde;o foi de 29,2 anos (DP=14,9). Dos 40    pacientes do ambulat&oacute;rio, 23 (57,5%; IC 95%: 40,9-73,0) eram do sexo    masculino e 17 (42,5%; IC 95%: 27,0-59,1) do sexo feminino, sendo a m&eacute;dia    de idade de 34,6 anos (DP=8,6).</font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000048
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!50
!v701!46
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">A freq&uuml;&ecirc;ncia    de doen&ccedil;a dermatol&oacute;gica entre os pacientes do hospital foi de    67,2% (n=133; IC 95%: 60,2-73,7). Entre esses pacientes com doen&ccedil;as dermatol&oacute;gicas,    o n&uacute;mero m&eacute;dio foi de 1,8 doen&ccedil;as (DP=1,2) para cada um.    Dos pacientes ambulatoriais, 30 (75,0%; IC 95%: 58,8-87,3) apresentaram doen&ccedil;a    dermatol&oacute;gica em alguma consulta, sendo que o n&uacute;mero m&eacute;dio    de doen&ccedil;as apresentadas foi de 1,6 doen&ccedil;as dermatol&oacute;gicas    (DP=0,6) para cada paciente.</font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000049
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!51
!v701!47
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">A doen&ccedil;a    dermatol&oacute;gica mais prevalente foi a candid&iacute;ase oral, independente    do grupo de pacientes (hospitalar ou ambulatorial), da idade e do sexo, seguida    por escabiose, herpes simples e dermatite seborr&eacute;ica (<a href="#t1">Tabela</a>).</font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000050
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!52
!v701!48
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p align="center"><a name="t1"></a></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000051
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!53
!v701!49
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p align="center">&nbsp;</p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000052
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!54
!v701!50
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p align="center"><img src="/img/revistas/rsp/v38n6/02t1.gif" width="528" height="326"></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000053
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!55
!v701!51
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p align="center">&nbsp;</p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000054
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!56
!v701!52
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">As contagens de    CD4 e de carga viral foram verificadas em 45 (22,7%) pacientes do hospital e    em 22 (55,0%) pacientes do ambulat&oacute;rio. Verificou-se que, na popula&ccedil;&atilde;o    hospitalar, entre os pacientes com doen&ccedil;a dermatol&oacute;gica, o n&uacute;mero    de c&eacute;lulas CD4 foi, em m&eacute;dia, 142,34 c&eacute;lulas/mm<sup>3</sup>    (DP=148,59). Entre os pacientes sem doen&ccedil;a dermatol&oacute;gica, essa    m&eacute;dia foi de 512,35 c&eacute;lulas/mm<sup>3</sup> (DP=636,49) (t=-3,78;    p=0,018). Na popula&ccedil;&atilde;o ambulatorial, tamb&eacute;m se verificou    uma diferen&ccedil;a estatisticamente significativa quanto &agrave; contagem    m&eacute;dia de linf&oacute;citos CD4: 138,88 c&eacute;lulas/mm<sup>3</sup>    (DP=162,14) entre os pacientes com doen&ccedil;a dermatol&oacute;gica e 336,21    c&eacute;lulas/mm<sup>3</sup> (DP=232,48) entre os pacientes sem doen&ccedil;a    dermatol&oacute;gica (t=-3,71; p=0,001). Ainda, em ambas as popula&ccedil;&otilde;es,    hospitalar e ambulatorial, verificou-se uma correla&ccedil;&atilde;o entre a    contagem de linf&oacute;citos CD4 e o n&uacute;mero total de doen&ccedil;as    dermatol&oacute;gicas apresentadas pelo paciente: quanto menor essa contagem,    maior o n&uacute;mero de doen&ccedil;as dermatol&oacute;gicas (<a href="#f1">Figuras    1</a> e <a href="#f2">2</a>) (p=0,000 e r<sup>2</sup>=0,23; e p=0,000 e r<sup>2</sup>=0,30,    respectivamente). N&atilde;o se verificou correla&ccedil;&atilde;o entre a carga    viral e a freq&uuml;&ecirc;ncia e/ou o n&uacute;mero de doen&ccedil;as dermatol&oacute;gicas.</font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000055
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!57
!v701!53
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p align="center"><a name="f1"></a></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000056
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!58
!v701!54
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p align="center">&nbsp;</p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000057
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!59
!v701!55
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p align="center"><img src="/img/revistas/rsp/v38n6/02f1.gif" width="429" height="384"></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000058
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!60
!v701!56
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p align="center">&nbsp;</p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000059
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!61
!v701!57
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p align="center"><a name="f2"></a></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000060
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!62
!v701!58
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p align="center">&nbsp;</p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000061
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!63
!v701!59
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p align="center"><img src="/img/revistas/rsp/v38n6/02f2.gif" width="430" height="368"></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000062
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!64
!v701!60
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p align="center">&nbsp;</p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000063
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!65
!v701!61
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Considerando a    popula&ccedil;&atilde;o hospitalar, dos 71 pacientes infectados pelo HIV que    se internaram no hospital sem esse diagn&oacute;stico, em 20 pacientes (28,2%;    IC 18,1-40,1) o motivo da solicita&ccedil;&atilde;o do teste anti-HIV foi doen&ccedil;a    dermatol&oacute;gica, isolada ou n&atilde;o. Desses, a doen&ccedil;a dermatol&oacute;gica    foi motivo isolado em seis (8,4%) pacientes.</font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000064
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!66
!v701!62
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p>&nbsp;</p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000065
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!67
!v701!63
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="3"><b>DISCUSS&Atilde;O</b></font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000066
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!68
!v701!64
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Como a maioria    dos pacientes de ambos os grupos estudados era do sexo masculino, mas como n&atilde;o    se trata de um estudo populacional e a amostra n&atilde;o &eacute; probabilista,    o resultado encontrado pode constituir-se em um vi&eacute;s de sele&ccedil;&atilde;o.    A literatura evidencia maior preval&ecirc;ncia de casos de infec&ccedil;&atilde;o    pelo v&iacute;rus HIV entre o sexo masculino.<sup>13</sup> A m&eacute;dia de    idade dos pacientes observada no presente estudo reafirma ser essa uma doen&ccedil;a    predominantemente de adultos jovens, conforme relatado previamente em outras    pesquisas.<sup>2,7,13</sup></font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000067
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!69
!v701!65
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Os resultados deste    estudo mostra que a freq&uuml;&ecirc;ncia de doen&ccedil;a dermatol&oacute;gica    foi de 67,2% entre os pacientes do hospital e de 75,0% entre os pacientes do    ambulat&oacute;rio, n&atilde;o sendo essa uma diferen&ccedil;a estatisticamente    significativa. Esses n&uacute;meros confirmam a alta preval&ecirc;ncia de doen&ccedil;as    dermatol&oacute;gicas entre os pacientes infectados pelo HIV. Estudos anteriores    realizados nos Estados Unidos<sup>4,9</sup> e Reino Unido<sup>17</sup> verificaram    uma varia&ccedil;&atilde;o nessa preval&ecirc;ncia de 64,0 a 91,4%, n&atilde;o    havendo diferen&ccedil;a na preval&ecirc;ncia de dermatoses entre ambos os sexos.</font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000068
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!70
!v701!66
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Deve-se considerar    que o diagn&oacute;stico das doen&ccedil;as dermatol&oacute;gicas foi feito,    na quase totalidade dos casos, pelo infectologista que acompanhava o paciente,    tanto no hospital quanto no ambulat&oacute;rio, e n&atilde;o por dermatologista.    No entanto, como j&aacute; citado anteriormente, as doen&ccedil;as dermatol&oacute;gicas    descritas foram as que tinham diagn&oacute;stico de certeza, seja pelo aspecto    cl&iacute;nico, seja pela confirma&ccedil;&atilde;o por exames complementares.</font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000069
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!71
!v701!67
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">A m&eacute;dia    de doen&ccedil;as dermatol&oacute;gicas foi 1,8 e 1,6 diferentes diagn&oacute;sticos    para cada paciente do hospital e do ambulat&oacute;rio, respectivamente. Essa    m&eacute;dia foi inferior &agrave; verificada em outros estudos,<sup>4,6,13,14</sup>    nos quais a freq&uuml;&ecirc;ncia de doen&ccedil;as dermatol&oacute;gicas variou    de 2,1 a 5,2 para cada paciente. Essa diferen&ccedil;a &eacute; devida, provavelmente,    ao pouco tempo de observa&ccedil;&atilde;o dos pacientes no presente estudo,    uma vez que s&oacute; se p&ocirc;de relatar as doen&ccedil;as manifestadas durante    os dias em que o paciente permaneceu hospitalizado ou durante a consulta ambulatorial.    Em outros estudos, nos quais o tempo de observa&ccedil;&atilde;o foi maior,    o n&uacute;mero de doen&ccedil;as dermatol&oacute;gicas tamb&eacute;m aumentou;    assim, Jensen et al<sup>6</sup> e Stern<sup>14</sup> verificaram, respectivamente,    uma m&eacute;dia de 5,2 e 3,7 doen&ccedil;as dermatol&oacute;gicas para cada    paciente, sendo que o tempo de observa&ccedil;&atilde;o do primeiro foi de cinco    anos; do &uacute;ltimo, 2,8 anos.</font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000070
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!72
!v701!68
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Conforme se observou,    a doen&ccedil;a dermatol&oacute;gica mais freq&uuml;ente, independente de sexo,    faixa et&aacute;ria ou contagem de linf&oacute;citos CD4, foi candid&iacute;ase    oral. Outras pesquisas<sup>6,7,13</sup> tamb&eacute;m relataram alta preval&ecirc;ncia    de candid&iacute;ase oral, sendo que Rico et al<sup>12</sup> referem ser essa    a doen&ccedil;a dermatol&oacute;gica mais comum entre os pacientes infectados    pelo HIV, ocorrendo em at&eacute; 50% deles ao longo do curso da doen&ccedil;a.    Myskowski &amp; Ahkami<sup>9</sup> e Porras et al<sup>10</sup> consideram a    dermatite seborr&eacute;ica como a doen&ccedil;a dermatol&oacute;gica mais associada    com a infec&ccedil;&atilde;o pelo HIV, ocorrendo em at&eacute; 80% dos pacientes.    No presente estudo, entre os pacientes que apresentavam alguma doen&ccedil;a    dermatol&oacute;gica, dermatite seborr&eacute;ica foi verificada em 12,8% dos    casos do hospital e em 10,0% dos casos do ambulat&oacute;rio. Seguindo-se &agrave;    candid&iacute;ase oral, as doen&ccedil;as dermatol&oacute;gicas mais freq&uuml;entes,    tanto no hospital quanto no ambulat&oacute;rio, foram escabiose (15,8% e 20,0%,    respectivamente) e herpes simples (15,8% e 16,6%, respectivamente). Porras et    al<sup>10</sup> referem que a escabiose &eacute; uma das doen&ccedil;as dermatol&oacute;gicas    mais freq&uuml;entes. Jensen et al<sup>6</sup> relatam que a infec&ccedil;&atilde;o    por herpes simples tamb&eacute;m est&aacute; entre as dermatoses mais prevalentes.    Rosatelli et al,<sup>13</sup> num estudo em Ribeir&atilde;o Preto, encontraram    preval&ecirc;ncia de 16,1% para infec&ccedil;&atilde;o por herpes simples e    de 4,0% para escabiose.</font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000071
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!73
!v701!69
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Constatou-se ainda    um caso de histoplasmose cut&acirc;nea e um outro de paracoccidioidomicose cut&acirc;nea,    ambos no grupo hospitalar. No estudo realizado em Ribeir&atilde;o Preto,<sup>13</sup>    no qual foram examinados 223 pacientes infectados pelo HIV entre 1989 e 1993,    foram relatados 14 casos de histoplasmose e tr&ecirc;s de paracoccidioidomicose.</font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000072
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!74
!v701!70
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Dentre as neoplasias,    o sarcoma de Kaposi &eacute; a que mais comumente ocorre entre os pacientes    infectados pelo HIV,<sup>10</sup> com uma freq&uuml;&ecirc;ncia de aproximadamente    15%.<sup>10,12</sup> N&atilde;o h&aacute; evid&ecirc;ncias suficientes de aumento    na incid&ecirc;ncia ou gravidade de c&acirc;ncer de pele &#151; carcinoma de    c&eacute;lulas escamosas, carcinoma de c&eacute;lulas basais ou melanoma maligno    &#151; entre os pacientes infectados pelo HIV.<sup>12</sup> Sabe-se que os c&acirc;nceres    de pele, especialmente os carcinomas de c&eacute;lulas escamosas, s&atilde;o    mais freq&uuml;entes em muitas popula&ccedil;&otilde;es de pacientes imunossuprimidos,    e est&atilde;o come&ccedil;ando a ser reconhecidos como potencial problema na    Aids.<sup>9</sup> Per&iacute;odos mais longos de observa&ccedil;&atilde;o, no    entanto, s&atilde;o necess&aacute;rios para avaliar o verdadeiro risco de c&acirc;ncer    de pele em pacientes infectados pelo HIV.<sup>9</sup> No presente estudo, verificou-se    um caso de sarcoma de Kaposi e dois casos de carcinoma de c&eacute;lulas basais.</font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000073
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!75
!v701!71
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Na estratifica&ccedil;&atilde;o    por sexo, dos diferentes diagn&oacute;sticos de doen&ccedil;as dermatol&oacute;gicas,    n&atilde;o se observou uma diferen&ccedil;a com signific&acirc;ncia estat&iacute;stica.    Barton &amp; Buchness<sup>1</sup> relatam que o espectro de preval&ecirc;ncia    de doen&ccedil;as dermatol&oacute;gicas em homens e mulheres infectados pelo    HIV n&atilde;o difere, &agrave; exce&ccedil;&atilde;o de uma maior freq&uuml;&ecirc;ncia    de sarcoma de Kaposi, leucoplasia oral e, possivelmente, onicomicose em homens.</font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000074
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!76
!v701!72
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Verificou-se diferen&ccedil;a    significante na contagem de linf&oacute;citos CD4 entre os pacientes com e sem    doen&ccedil;a dermatol&oacute;gica. Na popula&ccedil;&atilde;o hospitalar, para    os primeiros, a m&eacute;dia foi 142,34 c&eacute;lulas/mm<sup>3</sup>; para    os pacientes sem dermatose, a m&eacute;dia foi 512,35 c&eacute;lulas/mm<sup>3</sup>.    Na popula&ccedil;&atilde;o ambulatorial, as m&eacute;dias foram 138,88 c&eacute;lulas/mm<sup>3</sup>    e 336,21 c&eacute;lulas/mm<sup>3</sup>, respectivamente. Mirmirani et al<sup>8</sup>    tamb&eacute;m verificaram que pacientes com doen&ccedil;a dermatol&oacute;gica    apresentam contagem de linf&oacute;citos CD4 inferior &agrave; contagem de pacientes    sem doen&ccedil;a dermatol&oacute;gica. Tamb&eacute;m se observou, em ambas    as popula&ccedil;&otilde;es que, quanto maior o n&uacute;mero total de doen&ccedil;as    dermatol&oacute;gicas apresentadas pelo paciente, menor era a contagem de linf&oacute;citos    CD4. Em concord&acirc;ncia com esse &uacute;ltimo dado, Coopman et al<sup>4</sup>    e Myskowski &amp; Ahkami<sup>9</sup> verificaram que o n&uacute;mero total de    diagn&oacute;sticos de doen&ccedil;as dermatol&oacute;gicas aumenta de acordo    com a progress&atilde;o da doen&ccedil;a e/ou diminui&ccedil;&atilde;o da imunidade.    Tais dados evidenciam que as doen&ccedil;as dermatol&oacute;gicas s&atilde;o    importantes preditores cl&iacute;nicos da progress&atilde;o da infec&ccedil;&atilde;o    pelo HIV, havendo uma correla&ccedil;&atilde;o entre essas doen&ccedil;as, contagem    de CD4 e est&aacute;gio da doen&ccedil;a, em acordo com resultados de outras    pesquisas.<sup>6,7,17</sup> Destaca-se que, al&eacute;m da presen&ccedil;a de    doen&ccedil;a dermatol&oacute;gica para o progn&oacute;stico, importa tamb&eacute;m    o n&uacute;mero total de diferentes diagn&oacute;sticos dessas doen&ccedil;as    em cada paciente, sendo tamb&eacute;m referido por Jensen et al.<sup>6</sup></font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000075
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!77
!v701!73
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Al&eacute;m da    import&acirc;ncia no acompanhamento da doen&ccedil;a, as dermatoses podem auxiliar    o m&eacute;dico no diagn&oacute;stico da infec&ccedil;&atilde;o.<sup>11,12</sup>    Dos pacientes infectados pelo HIV do hospital cujo diagn&oacute;stico n&atilde;o    havia sido feito previamente &agrave; hospitaliza&ccedil;&atilde;o, em 28,2%    o motivo da solicita&ccedil;&atilde;o do teste anti-HIV foi a presen&ccedil;a    de doen&ccedil;a dermatol&oacute;gica, isolada ou n&atilde;o.</font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000076
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!78
!v701!74
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">As doen&ccedil;as    dermatol&oacute;gicas possuem uma alta preval&ecirc;ncia entre os pacientes    infectados pelo HIV, sendo as mais prevalentes candid&iacute;ase oral, escabiose    e herpes simples. A freq&uuml;&ecirc;ncia e o n&uacute;mero dessas afec&ccedil;&otilde;es    s&atilde;o indicadores do sistema imunol&oacute;gico do paciente e da progress&atilde;o    da doen&ccedil;a, havendo correla&ccedil;&atilde;o desses &iacute;ndices com    contagem de CD4. Uma vez feito o diagn&oacute;stico da infec&ccedil;&atilde;o,    muitas vezes suspeitado em raz&atilde;o de uma doen&ccedil;a dermatol&oacute;gica,    a avalia&ccedil;&atilde;o do paciente deve ser rotineira. Isso posto, &eacute;    de extrema relev&acirc;ncia que o m&eacute;dico conhe&ccedil;a as doen&ccedil;as    dermatol&oacute;gicas mais freq&uuml;entes entre os pacientes infectados pelo    HIV, o que pode auxili&aacute;-lo no diagn&oacute;stico e no acompanhamento    da doen&ccedil;a.</font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000077
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!79
!v701!75
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p>&nbsp;</p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000078
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!80
!v701!76
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica-Normal, sans-serif" size="3"><b>REFER&Ecirc;NCIAS</b></font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000079
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!81
!v701!77
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">1. Barton JC, Buchness    MR. Nongenital dermatologic disease in HIV-infected women. <i>J Am Acad Dermatol</i>    1999;40(6 Pt 1):938-48.</font></p>    ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v888!1
!v936!^i0034-8910^y2004^o6
!ID 0000080
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!82
!v701!78
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">2. Calikoglu E.    Cutaneous manifestations of HIV disease. <i>Emedicine</i> 2002. Available from:    URL:<a href="http://www.emedicine.com" target="_blank">http://www.emedicine.com</a></font></p>    ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v888!2
!v936!^i0034-8910^y2004^o6
!ID 0000081
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!83
!v701!79
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">3. Centers for    Diseases Control and Prevention. HIV and AIDS cases reported through December    2001. <i>HIV/AIDS Surveillance Rep</i> 2001;13:1-44.</font></p>    ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v888!3
!v936!^i0034-8910^y2004^o6
!ID 0000082
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!84
!v701!80
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">4. Coopman SA,    Johnson RA, Platt R, Stern RS. Cutaneous disease and drug reactions in HIV infection.    <i>N Engl J Med</i> 1993;328:1670-4.</font></p>    ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v888!4
!v936!^i0034-8910^y2004^o6
!ID 0000083
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!85
!v701!81
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">5. Costner M, Cockerell    CJ. The changing spectrum of the cutaneous manifestations of HIV disease. <i>Arch    Dermatol</i> 1998;134:1290-2.</font></p>    ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v888!5
!v936!^i0034-8910^y2004^o6
!ID 0000084
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!86
!v701!82
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">6. Jensen BL, Weismann    K, Sindrup JH, Sondergaard J, Schmidt K. Incidence and prognostic significance    of skin disease in patients with HIV/AIDS: a 5-year observational study. <i>Acta    Derm Venereol</i> 2000;80:140-3.</font></p>    ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v888!6
!v936!^i0034-8910^y2004^o6
!ID 0000085
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!87
!v701!83
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">7. Jing W, Ismail    R. Mucocutaneous manifestations of HIV infection: a retrospective analysis of    145 cases in a Chinese population in Malaysia. <i>Int J Dermatol</i> 1999;38:457-63.</font></p>    ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v888!7
!v936!^i0034-8910^y2004^o6
!ID 0000086
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!88
!v701!84
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">8. Mirmirani P,    Hessol NA, Maurer TA, Berger TG, Nguyen P, Khalsa A et al. Prevalence and predictors    of skin disease in the Women's Interagency HIV Study (WIHS). <i>J Am Acad Dermatol</i>    2001;44:785-8.</font></p>    ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v888!8
!v936!^i0034-8910^y2004^o6
!ID 0000087
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!89
!v701!85
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">9. Myskowski PL,    Ahkami R. Dermatologic complications of HIV infection. <i>Med Clin North Am</i>    1996;80:1415-35.</font></p>    ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v888!9
!v936!^i0034-8910^y2004^o6
!ID 0000088
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!90
!v701!86
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">10. Porras B, Costner    M, Friedman-Kien AE, Cockerell CJ. Update on cutaneous manifestations of HIV    infection. <i>Med Clin North Am</i> 1998;82:1033-80.</font></p>    ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v888!10
!v936!^i0034-8910^y2004^o6
!ID 0000089
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!91
!v701!87
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">11. Reynaud-Mendel    B, Janier M, Gerbaka J, Hakim C, Rabian C, Chastang C et al. Dermatologic findings    in HIV-1-infected patients: a prospective study with emphasis on CD4+ cell count.    <i>Dermatol</i> 1996;192:325-8.</font></p>    ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v888!11
!v936!^i0034-8910^y2004^o6
!ID 0000090
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!92
!v701!88
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">12. Rico MJ, Myers    SA, Sanchez MR. Guidelines of care for dermatologic conditions in patients infected    with HIV. Guidelines/Outcomes Committee. American Academy of Dermatology. <i>J    Am Acad Dermatol</i> 1997;37(3 Pt 1):450-72.</font></p>    ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v888!12
!v936!^i0034-8910^y2004^o6
!ID 0000091
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!93
!v701!89
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">13. Rosatelli JB,    Machado AA, Roselino AM. Dermatoses among Brazilian HIV-positive patients: correlation    with the evolutionary phases of AIDS. <i>Int J Dermatol</i> 1997;36:729-34.</font></p>    ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v888!13
!v936!^i0034-8910^y2004^o6
!ID 0000092
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!94
!v701!90
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">14. Stern RS. Epidemiology    of skin disease in HIV infection: a cohort study of health maintenance organization    members. <i>J Invest Dermatol</i> 1994;102:34S-37S.</font></p>    ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v888!14
!v936!^i0034-8910^y2004^o6
!ID 0000093
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!95
!v701!91
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">15. Supanaranond    W, Desakorn V, Sitakalin C, Naing N, Chirachankul P. Cutaneous manifestations    in HIV positive patients. <i>Southeast Asian J Trop Med Public Health</i> 2001;32:171-6.</font></p>    ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v888!15
!v936!^i0034-8910^y2004^o6
!ID 0000094
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!96
!v701!92
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">16. Szwarcwald    C, Castilho E. Estimativa do n&uacute;mero de pessoas de 15 a 49 anos infectadas    pelo HIV, Brasil, 1998: uma nota t&eacute;cnica. Bras&iacute;lia (DF): Minist&eacute;rio    da Sa&uacute;de. Coordena&ccedil;&atilde;o Nacional de DST/Aids; 1998.</font></p>    ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v888!16
!v936!^i0034-8910^y2004^o6
!ID 0000095
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!97
!v701!93
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">17. Uthayakumar    S, Nandwani R, Drinkwater T, Nayagam AT, Darley CR. The prevalence of skin disease    in HIV infection and its relationship to the degree of immunosuppression. <i>Br    J Dermatol</i> 1997;137:595-8.</font></p>    ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v888!17
!v936!^i0034-8910^y2004^o6
!ID 0000096
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!98
!v701!94
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p>&nbsp;</p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000097
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!99
!v701!95
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p>&nbsp;</p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000098
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!100
!v701!96
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><a name="back10"></a><a href="#top10"><img src="/img/revistas/rsp/v38n6/seta.gif" border="0"></a>    <b>Endere&ccedil;o para correspond&ecirc;ncia    ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000099
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!101
!v701!97
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<br>   </b>M&aacute;rcio Manozzo Boniatti    ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000100
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!102
!v701!98
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<br>   Rua &Acirc;ngelo Segalla, 622 Petr&oacute;polis    ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000101
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!103
!v701!99
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<br>   95070-420 Caxias do Sul, RS, Brasil    ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000102
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!104
!v701!100
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<br>   E-mail: <a href="mailto:marciobt@terra.com.br">marciobt@terra.com.br</a></font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000103
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!105
!v701!101
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Recebido em 15/4/2003.    Reapresentado em 8/4/2004. Aprovado em 1/6/2004</font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000104
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!106
!v701!102
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p>&nbsp;</p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000105
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!107
!v701!103
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p>&nbsp;</p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000106
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!108
!v701!104
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><a name="back1"></a><a href="#top10">*</a>    Doutorando do Curso de Medicina. Universidade de Caxias do Sul. Caxias do Sul,    RS, Brasil.    ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
!ID 0000107
!v002!S0034-8910(04)03800602
!v004!v38n6
!v700!109
!v701!105
!v702!C:\SciELO\Serial\rsp\v38n6\markup\02.htm
!v704!<br>   </font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Trabalho    realizado no Hospital Geral de Caxias do Sul e no Ambulat&oacute;rio Central    da Universidade de Caxias do Sul.</font></p>     ^cY
!v705!S
!v706!p
!v708!105
!v709!article
!v880!S0034-89102004000600002
!v882!^v38^n6
!v936!^i0034-8910^y2004^o6
